Keynote Speakers
Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas | 
Joshua Levin
Senior Group Leader, Research Scientist, Stanley Center for Psychiatric Research, Klarman Cell Observatory, The Broad Institute of MIT and Harvard | 
Clark Chen
Co-Director, University of California-San Diego | 
John Palma
Chief Medical Officer, Roche Sequencing Solutions | 
Shana Kelley
Professor, University of Toronto | 
Chwee Teck Lim
NUS Society Chair Professor, Department of Biomedical Engineering, Institute for Health Innovation & Technology (iHealthtech), Mechanobiology Institute, National University of Singapore |
OverviewThe Third Annual SELECTBIO Circulating Biomarkers World Congress 2016 brings together academic researchers as well as industry participants to present and discuss the most up-to-date research and commercial activities in the translation of various circulating biomarker classes towards the clinic.
The RNA-Seq and Digital PCR for Liquid Biopsies Conference Track brings together presenters from around the world to offer a comprehensive picture from research, commercial, and regulatory perspectives as to the deployment of biomarkers for precision medicine, and technical as well as economic and regulatory considerations in the development of liquid biopsies for the different cancer sub-classes as well as other disease areas.
A co-located exhibit hall features companies developing technologies and products for the complete workflow from sample isolation, preparation, through data analysis.
Conference delegates receive access to all three co-located conference tracks, can mix-and-match presentations from all three tracks thereby maximizing the conference experience, and can network with delegates from the various co-located tracks and exhibition.
Agenda Topics- Circulating Biomarkers vs. Tissue-based Biomarkers for Companion Diagnostics Development
- Companion Diagnostics in Various Disease Classes
- Autoimmune Disease
- Cancer
- Cardiovascular Disease
- CNS and Neurodegenerative Diseases
- Converting LDTs into FDA-Approved Tests
- Epigenetic Modifications (Hypermethylation of specific Genes) as Biomarkers for Diagnostics Development
- Next-Generation Sequencing (NGS) in Companion Diagnostics
- Potential of microRNAs as Biomarkers for Diagnostics Development
- Protein Biomarkers versus Nucleic Acid Biomarkers for Companion Diagnostics Development
- US vs. EU vs. Asia/Pacific Regulatory Landscape for Companion Diagnostics
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865
|
Confirmed Speakers to dateJohn F. Beeler, Vice President, Business Development, Inivata Ltd.
Mark Connelly, Chief Industrial Operations and R&D Officer, U.S., Menarini Silicon Biosystems, Inc.
Brian Dougherty, Executive Director, Translational Genomics, Oncology IMED, AstraZeneca R&D
Dana Gabuzda, Professor of Neurology, Dana-Farber Cancer Institute and Harvard Medical School
Jorge Goldstein, Senior Director, Sterne Kessler Goldstein and Fox PLLC
Laura Housman, Global Head, Pharmaceutical Business; Senior Vice President, Corporate Development, Molecular Health
Robert Kitchen, Research Associate, Yale University
Mike Makrigiorgos, Professor, Dana-Farber Cancer Institute/Harvard Medical School
Bakhos A. Tannous, Associate Professor of Neurology, Massachusetts General Hospital and Harvard Medical School
Dima Ter-Ovanesyan, PhD Student/George Church and Aviv Regev Laboratories, Harvard University
David Ting, Assistant Professor Of Medicine, Harvard Medical School
Yaoyu Wang, Associate Director, Dana-Farber Cancer Institute
|
|
All delegates receive the most up-to-date collection of academic literature, reviews as well as Powerpoint presentations related to exosomes, microvesicles, circulating nucleic acids, CTCs, liquid biopsies and companion diagnostics to complement the conference presentations. This collection of literature is accessible via the conference cloud for download by the conference delegates, is thorough and is an excellent resource for R&D planning, presentations, business planning and investor presentations.
|
|
Corporate Sponsors
|
Media Sponsors
|
|
Networking
|
|
|
|
|
|
|
Add to Calendar ▼2016-03-21 00:00:002016-03-22 00:00:00Europe/LondonRNA-Seq, Digital PCR, and Liquid Biopsies: Capturing Value from Circulating BiomarkersSELECTBIOenquiries@selectbiosciences.com
